U.S. Markets open in 5 hrs 32 mins

TYSON FOODS INC A DL-,10 (TF7A.MU)

Munich - Munich Delayed Price. Currency in EUR
Add to watchlist
64.600.00 (0.00%)
As of 8:00AM CEST. Market open.
Full screen
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close64.60
Open64.60
Bid64.04 x N/A
Ask64.56 x N/A
Day's Range64.60 - 64.60
52 Week Range48.67 - 64.91
Volume20
Avg. Volume26
Market CapN/A
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Bragar Eagel & Squire is Investigating Certain Officers and Directors of Uniti Group, Surgalign Holdings, Tyson Foods, and Tricida on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
    GlobeNewswire

    Bragar Eagel & Squire is Investigating Certain Officers and Directors of Uniti Group, Surgalign Holdings, Tyson Foods, and Tricida on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

    NEW YORK, April 09, 2021 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating certain officers and directors of Uniti Group, Inc. (NASDAQ: UNIT), Surgalign Holdings, Inc. (f/k/a RTI Surgical Holdings, Inc.) (Nasdaq: SRGA), Tyson Foods (NYSE: TSN), and Tricida, Inc. (NASDAQ: TCDA) on behalf of long-term stockholders. More information about each potential case can be found at the link provided. Uniti Group, Inc. (NASDAQ: UNIT) Bragar Eagel & Squire is is investigating certain officers and directors of Uniti Group, Inc. following news that the Shareholder Class Action Against Uniti Group has survived the motions to dismiss in the pending securities class action and may face damages. The complaint alleges that Uniti made materially false and/or misleading statements and/or failed to disclose that: (i) Uniti’s financial results were not sustainable because its customer Windstream had defaulted on its unsecured notes; and (ii) as a result of the foregoing, defendants’ statements about Uniti’s business, operations, and prospects, were false and misleading and/or lacked a reasonable basis. To learn more about our investigation into Uniti Group go to: https://bespc.com/cases/UNIT Surgalign Holdings, Inc. (f/k/a RTI Surgical Holdings, Inc.) Bragar Eagel & Squire is is investigating certain officers and directors of Surgalign Holdings, Inc. (f/k/a RTI Surgical Holdings, Inc.), following news that the Shareholder Class Action Against Surgalign has survived the motions to dismiss in the pending securities class action and may face damages. According to the lawsuit, defendants throughout the class period made false and/or misleading statements and/or failed to disclose that: (1) the Company inappropriately recognized revenues with respect to certain contractual arrangements, including other equipment manufacturer customers; (2) the Company’s internal controls over financial reporting were not effective; (3) as a result, the Company would be forced to delay the filing of its Form 10-K for fiscal year ended December 31, 2019; and (4) as a result, defendants' statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times. To learn more about our investigation into Surgalign go to: https://bespc.com/cases/SRGA Tyson Foods, Inc. (NYSE: TSN) Bragar Eagel & Squire is investigating certain officers and directors of Tyson Foods, Inc. following a class action complaint that was filled against Tyson on February 2, 2021. The complaint alleges that defendants throughout the class period made false and/or misleading statements and/or failed to disclose that: (1) Tyson knew, or should have known, that the highly contagious coronavirus was spreading throughout the globe; (2) Tyson did not in fact have sufficient safety protocols to protect its employees in its facilities; (3) as a result, Tyson employees contracted and spread the coronavirus within the facilities; (4) as a result of the foregoing, Tyson would face negative impact to its production, including complete shutdowns of certain facilities; (5) due to the failure to protect its employees, Tyson would suffer financial harm related to its lowered production; and (6) as a result, defendants’ public statements were materially false and/or misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages. For more information on the Tyson Foods investigation go to: https://bespc.com/cases/TSN Tricida, Inc. (NASDAQ: TCDA) Bragar Eagel & Squire is investigating certain officers and directors of Tricida, Inc. following a class action complaint that was filled against Tricida on January 6, 2021. The complaint alleges that throughout the class period defendants made materially false and misleading statements, and failed to disclose material adverse facts about the Company’s business, operational, and compliance policies. Specifically, defendants made false and/or misleading statements and failed to disclose to investors that: (i) Tricida’s NDA for veverimer was materially deficient; (ii) accordingly, it was foreseeably likely that the FDA would not accept the NDA for veverimer; and (iii) as a result, the Company’s public statements were materially false and misleading at all relevant times. For more information on the Tricida investigation go to: https://bespc.com/cases/TCDA About Bragar Eagel & Squire, P.C.:Bragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York, California, and South Carolina. The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country. For more information about the firm, please visit www.bespc.com. Attorney advertising. Prior results do not guarantee similar outcomes. Contact Information:Bragar Eagel & Squire, P.C.Brandon Walker, Esq. Melissa Fortunato, Esq.Marion Passmore, Esq.(212) 355-4648investigations@bespc.comwww.bespc.com

  • Tyson Foods' (TSN) New Tennessee Facility to Bolster Capacity
    Zacks

    Tyson Foods' (TSN) New Tennessee Facility to Bolster Capacity

    Tyson Foods (TSN) opens a poultry complex including processing plant, feed mill and hatchery in Humboldt, Tennessee. The facility will start production by April end.

  • Tyson Foods Officially Opens New $425M Tennessee Poultry Complex
    SmarterAnalyst

    Tyson Foods Officially Opens New $425M Tennessee Poultry Complex

    Tyson Foods has invested $425 million in a new poultry complex in Humboldt, Tennessee that was officially opened on April 8. The new poultry complex is the food company’s biggest investment in Tennessee and “the single largest corporate investment ever in Gibson County.” Tyson Foods’ (TSN) President and CEO, Dean Banks said, “We’re pleased to add to the growth in Gibson County with the opening of our new 370,000 square foot processing facility. We appreciate the support of all those who played a role in making this facility possible—the local community, county, state and our Humboldt team members, who safely and responsibly produce high-quality protein daily to help feed our nation and the world.” The poultry complex includes a hatchery, feed mill and a processing plant and is expected to employ 1,500 people by 2023. Production is expected to start in the later part of this month and will produce “pre-packaged trays of fresh chicken for retail grocery stores nationwide”. (See Tyson Foods stock analysis on TipRanks) Earlier this month, Merrill Lynch analyst Peter Galbo raised the price target from $72 to $76 but reiterated a Hold rating on the stock. Overall, the rest of the Street is cautiously optimistic on the stock with a Moderate Buy consensus rating based on 1 Buy and 1 Hold. The average analyst price target of $78 implies that TSN shares have approximately 2.2% upside potential to current levels. Shares of TSN have risen 18.1% in the past three months. According to the TipRanks Smart Score system, TSN scores a 6 out of 10 indicating that the stock is likely to perform in line with market averages. Related News: Conagra Brands 3Q Revenues And Profits Beat Estimates; Street Says Hold Okta Reaffirms Financial Outlook, Launches New Products On Investor Day Costco’s Comps Climb 11.1% In March More recent articles from Smarter Analyst: Provention Bio Shares Crash 40% Due To Regulatory Setback For Diabetes Drug Friday’s Pre-Market: Here’s What You Need To Know Before The Market Opens UPS Plans To Acquire Beta Technologies’ Aircraft To Enhance Air Delivery Services Conagra Brands 3Q Revenues And Profits Beat Estimates; Street Says Hold